Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: A double-blind, placebo-controlled study

Pain

Volumn 76, Issue 1-2, 1998, Pages 17-26

  Santillán, Rosa ^a   Hurlé, María A ^b   Armijo, Juan A ^b   De Los Mozos, Rosario ^a   Flórez, Jesús ^b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Morphine; Nimodipine; Opiate tolerance; Opioid analgesic; Placebo control

Indexed keywords

ACETYLSALICYLIC ACID; ALIZAPRIDE; ALMAGATE; AMITRIPTYLINE; BROMAZEPAM; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; DIPYRONE; FLUNITRAZEPAM; HALOPERIDOL; KETOROLAC; LACTULOSE; LORAZEPAM; LORMETAZEPAM; MAGALDRATE; MORPHINE; NAPROXEN; NIMODIPINE; ONDANSETRON; PARACETAMOL; RANITIDINE;

ADULT; AGED; AGITATION; ARTICLE; CANCER PAIN; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERANCE; DYSPEPSIA; FEMALE; HEADACHE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

AGED; ANALGESICS, OPIOID; BIOTRANSFORMATION; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; NIMODIPINE; PAIN, INTRACTABLE;

EID: 0031745823     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00019-0     Document Type: Article

References (42)

1. Alfaro M.J., Colado M.I., López F., Martín M.I. Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal rsponse in the guinea-pig ileum. Br. J. Pharmacol. 101:1990;958-960.
2. Antkiewicz-Michaluk L., Michaluk J., Romanska I., Vetulani J. Cortical dihydropyridine binding sites and behavioral syndrome in morphine-abstinent rats. Eur. J. Pharmacol. 180:1993;129-135.
3. Baeyens J.M., Esposito E., Ossowska G., Samanin R. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur. J. Pharmacol. 137:1987;9-13.
4. Barrios M., Baeyens J.M. Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro. Eur. J. Pharmacol. 152:1988;175-178.
5. Boldt J., von Bormann B., Kling D., Russ W., Ratthey K., Hempelman G. Low-dose fentanyl analgesia modified by calcium channel blockers in cardiac surgery. Eur. J. Anesthesiol. 4:1987;387-394.
6. Bongiani F., Carla V., Moroni F., Pellegrini-Giampietro D.E. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br. J. Pharmacol. 88:1986;561-567.
7. Carta F., Bianchi M., Argenton S., Cervi D., Marolla G., Tamburini M., Breda M., Fantoni A., Panerai A.E. Effect of nifedipine on morphine-induced analgesia. Anesth. Analg. 70:1990;493-498.
8. Chapman D.B., Way E.L. Metal ion interactions with opiates. Annu. Rev. Pharmacol. Toxicol. 20:1980;553-579.
9. Colado M.I., Alfaro M.J., López F., del Val V., Martín M.I. Effect of nimodipine, diltiazem and Bay K 8644 on the behavioral and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. Gen. Pharmacol. 24:1993;35-41.
10. Collin E., Cesselin F. Neurobiological mechanisms of opioid tolerance and dependence. Clin. Neuropharmacol. 14:1991;465-488.
11. ++ channels during opioid tolerance and supersensitivity in rats, J. Pharmacol. Exp. Ther., 274 (1995a) 1545-1551.
12. Díaz, A., Ruiz, F., Flórez, J., Hurlé, M.A. and Pazos, A., Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system, J. Pharmacol. Exp. Ther., 274 (1995b) 1545-1551.
13. Díaz A., Dickenson A.H. Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurones produced by subcutaneous formalin inflammation. Pain. 69:1997;93-100.
14. Dierssen M.M., Flórez J., Hurlé M.A. Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions. Naunyn-Schmidebergs's Arch. Pharmacol. 342:1990;559-565.
15. Filos K.S., Goudas L.C., Patroni O., Tassoudis V. Analgesia with epidural nimodipine. Lancet. 342:1993;1047.
16. Foley, K.M., Clinical Tolerance to opioids. In: A.Y. Basbaum and J.M. Besson (Eds.), Towards a New Pharmacotherapy of Pain, Wiley, New York, 1991, pp. 181-203.
17. ++ uptake, J. Pharmacol. Exp. Ther., 209 (1979a) 132-136.
18. Guerrero-Muñoz, F., Guerrero, M.L. and Way, E.L., Effect of morphine on calcium uptake by lysed synaptosomes, J. Pharmacol. Exp. Ther., 211 (1979b) 370-374.
19. Harris R.A., Yamamoto H., Loh H.H., Way E.L. Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinence. Life Sci. 20:1977;501-506.
20. Joel S.P., Osborne R.J., Slevin M.L. An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites. J. Chromatog. 430:1988;394-399.
21. Lehmann K.A., Kriegel R., Ueki M. Zur klinischen bedeutung von arzneimittelinteraktionen zwischen opiaten und kalziumantagonisten. Anaesthesist. 38:1989;110-115.
22. Malmberg A.B., Yaksh T.L. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci. 14:1994;4882-4890.
23. Manning B.H., Mao J., Frenk H., Price D.D., Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain. 67:1996;79-88.
24. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
25. Milne R.W., Nation R.L., Reynolds G.D., Somogyi A.A., Van Crugten J.T. High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application of stability studies. J. Chromatog. 565:1991;457-464.
26. Nestler E.J. Molecular neurobiology of drug addiction. Neuropsychopharmacology. 11:1994;77-87.
27. 3H-nitrendipine binding to synaptic membranes: Similarity with morphine tolerance. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;123-127.
28. 3H-noradrenaline release. Br. J. Pharmacol. 93:1988;535-540.
29. Portenoy, R.K., Tolerance to opioid analgesics: clinical aspects. In: Cancer Surveys Vol. 21: Palliative Medicine: Problem Areas in Pain and Symptom Management, Imperial Cancer Research Fund, 1994, pp. 49-65.
30. 3H-nitrendipine binding sites in the brain in morphine-tolerant mice. Eur. J. Pharmacol. 102:1984;371-372.
31. Ramkumar V., El-Fakahany E.E. Prolonged morphine treatment increases rat brain dihydropyridine binding sites: Possible involvement in development of morphine dependence. Eur. J. Pharmacol. 146:1988;73-83.
32. Roca G., Aguilar J. L, Gomar C., Mazo V., Costa J., Vidal F. Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment. Pain. 68:1996;239-243.
33. Ruiz F., Dierssen M.M., Flórez J., Hurlé M.A. Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats. Eur. J. Pharmacol. 348:1993;633-637.
34. 3H-nitrendipine binding following chronic treatment with morphine. Neurochem. Int. 7:1985;1033-1036.
35. Santillán R., Maestre J.M., Hurlé M.A., Flórez J. Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine. A preliminary report. Pain. 58:1994;129-132.
36. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-495.
37. Szikszay M., Snyder F.R., London E.D. Effects of Diltiazem on morphine-induced respiratory decline. J. Pharm. Pharmacol. 38:1986;625-627.
38. Sunahara R.K., Dessauer C., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36:1996;461-480.
39. Von Bormann B., Boldt J., Sturm G. Calciumantagonisten in der anaesthesie: additive analgesie durch nimodipin waehrend cardiochirugischer eingriffe. Anaesthesist. 34:1985;429-434.
40. Welch S.P., Olson K.G. Opiate tolerance-induced modulation of free intracellular calcium synaptosomes. Life Sci. 48:1991;1853-1861.
41. Yamamoto H., Harris R.A., Loh H.H., Way E.L. Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J. Pharmacol. Exp. Ther. 205:1978;255-264.
42. Zharkovsky A., Tötterman A.M., Moisio J., Athee L. Concurrent nimodipine attenuates the withdrawal signs and the increase of dihydropyridine binding after chronic morphine treatment in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;483-486.